KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Change in Accured Expenses (2016 - 2025)

Charles River Laboratories International has reported Change in Accured Expenses over the past 17 years, most recently at -$2.6 million for Q4 2025.

  • Quarterly results put Change in Accured Expenses at -$2.6 million for Q4 2025, up 90.0% from a year ago — trailing twelve months through Dec 2025 was $79.3 million (up 387.31% YoY), and the annual figure for FY2025 was $79.3 million, up 387.31%.
  • Change in Accured Expenses for Q4 2025 was -$2.6 million at Charles River Laboratories International, down from $42.9 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for CRL hit a ceiling of $51.3 million in Q2 2021 and a floor of -$79.8 million in Q1 2022.
  • Median Change in Accured Expenses over the past 5 years was $4.9 million (2021), compared with a mean of $3.3 million.
  • Biggest five-year swings in Change in Accured Expenses: skyrocketed 563.47% in 2023 and later crashed 188.33% in 2024.
  • Charles River Laboratories International's Change in Accured Expenses stood at $26.1 million in 2021, then plummeted by 136.14% to -$9.4 million in 2022, then plummeted by 69.58% to -$16.0 million in 2023, then crashed by 60.23% to -$25.6 million in 2024, then soared by 90.0% to -$2.6 million in 2025.
  • The last three reported values for Change in Accured Expenses were -$2.6 million (Q4 2025), $42.9 million (Q3 2025), and $23.7 million (Q2 2025) per Business Quant data.